What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Global Longlife Hospital and Research Limited IPO?

Global Longlife Hospital and Research Limited IPO has received a total subscription of 0.00 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Global Longlife Hospital and Research Limited

ListedSME

Healthcare · BSE

Global Longlife Hospital and Research Limited is an NABH-accredited multi-speciality tertiary care hospital based in Ahmedabad, Gujarat, offering a wide range of healthcare services including oncology, ophthalmology, cardiology, dermatology, gynecology, spine and plastic surgery, dialysis, physiotherapy, ultrasound, and microbiology. The hospital has a capacity of 110 well-equipped beds supporting both medical and surgical specialties, and as of December 31, 2021, it is supported by 11 full-time consultants, over 30 experienced consulting doctors, 37 nurses, and more than 50 paramedical, pharmacy, corporate, and support staff, ensuring comprehensive and quality patient care.

Price Band

₹140

Issue Size

₹49.00 Cr

Lot Size

1000 shares

GMP

₹1

+0.7%

Est. Listing

₹141

at current GMP

Subscribed

—

Open

21 Apr 2022

25 Apr 2022

Allotment

30 Apr 2022

Refund

1 May 2022

Demat Credit

2 May 2022

Listing

4 May 2022

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

0.00x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 0.00x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	1,750,000	—	0.00x
Non-Institutional (NII / HNI)	525,000	—	0.00x
Retail Individual (RII)	1,225,000	—	0.00x
Total	3,500,000	0	0.00x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.00x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	1,225	1,225	1.00x
HNIs (10L +)	8	8	1.00x
HNIs (2-10L)	38	38	1.00x
Total Applications	1,271	1,271	1.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Global Longlife Hospital and Research Limited Public Issue & Market Profile

Global Longlife Hospital and Research Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹49 Crores. The shares are offered at a price band of ₹140 to ₹140 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,40,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2022-05-02, while un-allotted funds or UPI block mandates will be released on 2022-05-01.

Frequently Asked Questions

What is Global Longlife Hospital and Research Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Global Longlife Hospital and Research Limited IPO is ₹1 per equity share. Based on the upper price band of ₹140 to ₹140 per equity share, the estimated listing price is ₹141 (+0.7% expected listing gain).

What is the expected profit per lot for Global Longlife Hospital and Research Limited IPO?

With a lot size of 1000 shares and current GMP of ₹1, the expected profit per application lot is approx ₹1,000 (+0.7% gain). Minimum application cost is approx ₹1,40,000.

What is the issue size and price band for Global Longlife Hospital and Research Limited IPO?

The Global Longlife Hospital and Research Limited IPO aggregate issue size is ₹49 Crores with an equity price band set at ₹140 to ₹140 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,40,000.

How can I check Global Longlife Hospital and Research Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Global Longlife Hospital and Research Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2022-04-30. Investors can verify status using PAN card or application number.

When is the listing date for Global Longlife Hospital and Research Limited IPO?

Global Longlife Hospital and Research Limited shares are scheduled to list on BSE on 2022-05-04.